[1]
Abdul Latif Mahesar et al. 2025. EFFICACY AND SAFETY OF SODIUM-GLUCOSE CO-TRANSPORTER (SGLT2 ) INHIBITORS ON CARDIOVASCULAR AND RENAL OUTCOMES IN OBESE DIABETIC PATIENTS, A RETROSPECTIVE COHORT ANALYSIS. Journal of Population Therapeutics and Clinical Pharmacology. 32, 3 (Mar. 2025), 1472–1481. DOI:https://doi.org/10.53555/8vp1s226.